Income Statement

v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating cost and expense    
Plant operations $ 724,000 $ 2,209,000
Research and development cost 336,000 588,000
Impairment expense 5,247,000 0
General and administrative expense 2,376,000 2,995,000
Total operating expense 8,683,000 5,792,000
Loss from operations (8,683,000) (5,792,000)
Other income and (expense)    
Interest expense (403,000) (106,000)
Interest and Other Income 280,000 146,000
Change in fair value of warrant liability 491,000 0
Total other income, net 368,000 40,000
Net loss $ (8,315,000) $ (5,752,000)
Weighted average shares outstanding, basic and diluted (in shares) 8,095,716 5,502,730
Basic and diluted net loss per share (in dollars per share) $ (1.03) $ (1.05)

Source